• Exchange: Mexico
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Gilead Sciences Inc

+ Add to Watchlist

GILD*:MM

1,381.35 MXN 38.36 2.86%

As of 16:09:02 ET on 12/26/2014.

Snapshot for Gilead Sciences Inc (GILD*)

Open: 1,379.00 Day's Range: 1,375.00 - 1,385.50 Volume: 9,276
Previous Close: 1,342.99 52wk Range: 856.00 - 1,620.00 1-Yr Rtn: +41.60%

Stock Chart for GILD*

No chart data available.
  • GILD*:MM 1,381.35
  • 1D
  • 1M
  • 1Y
1,342.99
Interactive GILD* Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GILD*

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 11.8448
Relative P/E vs. MEXBOL -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 7.9360
Est. PEG Ratio 0.4829
Market Cap (M MXN) 2,083,993.48
Shares Outstanding (M) 1,508.66
30 Day Average Volume 16,352
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GILD*

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GILD*

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.

John C MartinChairman/CEOJohn F MilliganPresident/COO
Robin L WashingtonExec VP/CFOJohn G McHutchisonExec Vice President
More Company Profile & Key Executives for GILD*

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil